A Study of Selumetinib in Patients With Kaposi's Sarcoma (SCART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01752569
Recruitment Status : Active, not recruiting
First Posted : December 19, 2012
Last Update Posted : January 10, 2018
University of Birmingham
Thermo Fisher Scientific
Cancer Research UK
University of Sheffield
Information provided by (Responsible Party):
Sheffield Teaching Hospitals NHS Foundation Trust

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 2018
  Estimated Study Completion Date : June 2018